Lord, Abbett & Co. LLC Axogen, Inc. Transaction History

Lord, Abbett & Co. LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$14.62 - $22.13 $1.56 Million - $2.37 Million	-106,905 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$17.09 - $38.25 $44,570 - $99,756	2,608 Added 2.5%	106,905 $2.18 Million
Q3 2018 Nov 14, 2018	SELL	$34.05 - $55.9 $8.51 Million - $14 Million	-249,848 Reduced 70.55%	104,297 $3.84 Million
Q2 2018 Aug 14, 2018	SELL	$36.15 - $52.5 $245,350 - $356,317	-6,787 Reduced 1.88%	354,145 $17.8 Million
Q1 2018 May 15, 2018	BUY	$24.4 - $40.25 $4.7 Million - $7.75 Million	192,558 Added 114.36%	360,932 $13.2 Million
Q4 2017 Feb 14, 2018	BUY	$18.5 - $28.6 $3.11 Million - $4.82 Million	168,374	168,374 $4.77 Million

176

36.6M

230K

400

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $749M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

Stay updated on Lord, Abbett & Co. LLC with notifications on news.